Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-98-002020
Filing Date
1998-03-30
Accepted
1998-03-30 00:00:00
Documents
8
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 CAMBRIDGE NEUROSCIENCE, INC. 10-K 216444
2 1992 DIRECTOR STOCK OPTION PLAN EX-10.12 11358
3 FOURTH AMENDMENT TO LEASE EX-10.13 10679
4 COMPENSATORY ARRANGEMENT EX-10.25 1327
5 SUBSIDIARIES EX-21.1 484
6 CONSENT OF ERNST & YOUNG EX-23.1 851
7 FACTORS REGARDING FORWARD LOOKING STATEMENTS EX-99.1 47913
8 FINANCIAL DATA SCHEDULE EX-27 2311
  Complete submission text file 0000950135-98-002020.txt   293661
Mailing Address ONE KENDALL SQ BLDG 700 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ BUILD 700 CAMBRIDGE MA 02139 6172250600
CAMBRIDGE NEUROSCIENCE INC (Filer) CIK: 0000874384 (see all company filings)

EIN.: 133319074 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19193 | Film No.: 98579073
SIC: 2834 Pharmaceutical Preparations